Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases
Clinical trial NCT02913417 · UNKNOWN
Trial details
- NCT number
- NCT02913417
- Sponsor
- David Minor, MD
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-10
- Primary completion
- 2022-01-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.